Metformin decreases serum 8-hydroxy-2′-deoxyguanosine levels in polycystic ovary syndrome
Authors:
- Henri SovaHSHenri Sova
- Ulla PuistolaUPUlla Puistola
- Laure Morin-PapunenLMLaure Morin-Papunen
- Peeter KarihtalaPKPeeter Karihtala
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 99 (2) , 593-598
Abstract
No abstract availableKeywords
Funding Information
- Suomen Lääketieteen Säätiö
- Suomen Kulttuurirahasto
- Ono Medical Research Foundation
This publication has 43 references indexed in Scilit:
- Metformin and Other Biguanides in Oncology: Advancing the Research AgendaCancer Prevention Research, 2010
- Metformin Prevents Tobacco Carcinogen–Induced Lung TumorigenesisCancer Prevention Research, 2010
- 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancerBritish Journal of Cancer, 2010
- New Users of Metformin Are at Low Risk of Incident CancerDiabetes Care, 2009
- Oxidative Stress Biomarkers and Lifestyles in Japanese Healthy PeopleJournal of Clinical Biochemistry and Nutrition, 2009
- Nuclear oxidative damage correlates with poor survival in colorectal cancerBritish Journal of Cancer, 2008
- Base-excision repair of oxidative DNA damageNature, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patientsClinical and Experimental Immunology, 2006
- The Molecular Basis for Oxidative Stress-Induced Insulin ResistanceAntioxidants & Redox Signaling, 2005